On 4/11/2017, Shares of Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) closed at $0.618 in last trading day. After noting the initial trading entry at $0.670, it reached to a day’s high of $0.698 and moved to a day’s low of $0.573. The recent daily volume was 13.1 million as contrast to it’s an average volume of 5.47 million.
The last close of the Rexahn Pharmaceuticals, Inc. stock reflects that it traded up +47.729% from its 50-day moving average of $0.418. The stock traded above +157.265% to its 200-day MA of $0.240. Furthermore, it moved lower -12.958% from its 52-week high of $0.710 and +386.614% up from $0.127, which is 52-week low of the stock.
Rexahn Pharmaceuticals, Inc.’s (RNN) moved with shift of -3.44% in the past week. Over the last three months, the shares of the company have changed 270.73% and performed 194.29% over the last six months. The stock currently has Monthly Volatility of 12.71% and Weekly Volatility of 12.92%.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer. The company’s clinical stage drug candidates include RX-3117, which is in Phase IIa clinical trial for the treatment of patients with relapsed or refractory pancreatic cancer, and advanced bladder cancer; and Supinoxin that is in Phase IIa clinical study to treat patients with metastatic triple negative breast cancer. It is also developing Archexin, which has completed a pilot Phase IIa clinical trial for the treatment of pancreatic cancer; and is in Phase IIa clinical trial to treat patients with metastatic renal cell carcinoma. In addition, the company is involved in developing RX-21101, an N-(2-Hydroxypropyl) methacrylamide-docetaxel-folate, which is in pre-clinical development stage used for the treatment of tumors. Rexahn Pharmaceuticals, Inc. is based in Rockville, Maryland.
Arista Networks, Inc. (NYSE:ANET) finalized the last transaction at value of $133.33, with a daily change of +0.05% or +0.06 points. The company maintained volume of 497.31 thousand shares. In past trading day, the stock hit the maximum price of $134.25 and touched to minimum value of $131.47. It has a market cap of $ 9.47B.
As of last trade close, the stock is trading downside -1.43% from its one year high of $135.27 and moved +120.34% upward from $60.51, which is one year low of the stock.
The stock traded above +4.82% from its 50-day moving average of $127.20. Furthermore, the stock moved up +31.96% to its 200-day MA of $ 101.04.
During the last month, Arista Networks, Inc.’s (ANET) has changed 4.60% and performed 54.09% over the last 6 months. The mean rating score for this stock is at 2.20. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 1.73% in recent month and observed Weekly Volatility of 1.55%.
Arista Networks, Inc. supplies cloud networking solutions in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company’s cloud networking solutions consist of its Extensible Operating System and a set of network applications, as well as gigabit Ethernet switching and routing platforms, including universal leaf, spline, and universal spine products. It also provides post contract customer support services, such as technical support, hardware repair and parts replacement beyond standard warranty, bug fix, patch, and upgrade services. The company serves a range of industries comprising Internet companies, service providers, financial services organizations, government agencies, media and entertainment companies, and others. It markets and sells its products through distributors, value-added resellers, system integrators, and original equipment manufacturer partners, as well as through its direct sales force. The company was formerly known as Arastra, Inc. and changed its name to Arista Networks, Inc. in October 2008. Arista Networks, Inc. was founded in 2004 and is headquartered in Santa Clara, California.